The report covers forecast and analysis for the pruritus therapeutics market on a global and regional level. The study provides historic data of 2014 and 2015 along with a forecast from 2016 to 2022 based on revenue (USD Billion).
The study includes drivers and restraints for the pruritus therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Pruritus therapeutics market on a global level.
The therapeutic type based market covered under this study includes antihistamines, topical corticosteroids, opioid receptor antagonists, topical immunomodulators, antidepressants, immunosuppressants, topical local anesthetics, cannabinoid receptors and others.
- Increasing prevalence of atopic dermatitis
- Development of new drug and a strong pipeline
Global Pruritus Therapeutics Market Restraints: Impact Analysis
- Lack of awareness about pruritus
- Untapped market and increasing number of patent expiry of pruritus drugs
Key Topics Covered:
2. Executive Summary
3. Pruritus Therapeutics Market Market Dynamics
4. Global Pruritus Therapeutics Market Competitive Landscape
5. Global Pruritus Therapeutics Market Therapeutic Analysis
6. Global Pruritus Therapeutics Market Regional Segment Analysis
7. Company Profiles
- Allergan Inc.
- Amgen Inc.
- Astellas Pharma Inc.
- CARA Therapeutics
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Ajanta Pharma ltd.
- Abbot lab
- GlaxoSmithKline plc.
For more information about this report visit https://www.researchandmarkets.com/research/lfxdq4/pruritus